All Stories

  1. Discussing recent advances and perspectives in GLP-1 based therapies for type 2 diabetes treatment

    Article • F1000Research, April 2020, Faculty of 1000, Ltd.

    Professor Stephen Charles Bain, Venkateswarlu Kanamarlapudi, Joshua reed

  2. Efficacy of newer agents in the glycaemic management of patients with type 2 diabetes

    Article • Current Medical Research and Opinion, November 2019, Taylor & Francis

    Professor Stephen Charles Bain

  3. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

    Article • Journal of Medical Economics, August 2019, Taylor & Francis

    Professor Stephen Charles Bain, Mr Barrie D Chubb, Brian Bekker Hansen, Barnaby Hunt, Emma McBeath

  4. Cardiovascular safety of liraglutide for the treatment of type 2 diabetes

    Article • Expert Opinion on Drug Safety, April 2017, Taylor & Francis

    Professor Stephen Charles Bain

  5. Looking to a future of improved diabetes management: interview with Professor Steve Bain

    Article • Future Science OA, December 2016, Future Science

    Professor Stephen Charles Bain

  6. An interview with Professor Steve Bain: the LEADER trials and the future of type 2 diabetes

    Article • Expert Review of Endocrinology & Metabolism, September 2016, Taylor & Francis

    Professor Stephen Charles Bain

  7. A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment

    Article • Drug Design Development and Therapy, August 2013, Taylor & Francis

    Professor Stephen Charles Bain